Scroll down to search for clinics conducting this clinical trial.

Study summary

<b>Multiple Sclerosis - Multiple Locations in the US</b>
    EMBOLD: Evaluating a Potential Approach for Progressive Forms of MS

    What’s next in research for non-active progressive MS
    The EMBOLD Study is evaluating a new potential investigational treatment designed for progressive MS that gets worse with time but doesn’t include relapses (non-active primary and secondary progressive multiple sclerosis).

    EMBOLD at a Glance
    • Up to 200 participants
    • Five years of participation
    • All participants will receive the investigational treatment at certain points in the study.
    You may be eligible if:*
    • You are aged 18 to 60 and diagnosed with progressive multiple sclerosis without relapses
    • You’ve never tried Lemtrada® (alemtuzumab), Mavenclad® (cladribine), stem cell transplant, or EBV T-cell therapy
    • You are able to walk 30 feet or more with or without the help of a cane or walker

    *Other eligibility criteria will apply.

    All participants will receive the investigational treatment and study-related care and monitoring at no cost. Travel support and reimbursements may also be available.

    CLICK HERE for more information.

    Study is available at

    This study is being conducted NATIONWIDE! To find clinics conducting this study near you please use search feature below.

    Study Locations